Clinical Outcomes in Patients with Severe Aortic Valve Stenosis Treated with a Portico Transcatheter Aortic Valve System

Publication

Clinical Outcomes in Patients with Severe Aortic Valve Stenosis Treated with a Portico Transcatheter Aortic Valve System

Journal Paper/Review - May 15, 2019

Pozzoli Alberto, Taramasso Maurizio, Haager Philipp K., Miura Mizuki, Gülmez Gökhan, Lin Shu-I, Gavazzoni Mara, Rickli Hans, Maisano Francesco

Units

Kardiologie

PubMed

31095721

Citation

Pozzoli A, Taramasso M, Haager P, Miura M, Gülmez G, Lin S, Gavazzoni M, Rickli H, Maisano F. Clinical Outcomes in Patients with Severe Aortic Valve Stenosis Treated with a Portico Transcatheter Aortic Valve System. Surg Technol Int 2019; 34:331-338.

Type

Journal Paper/Review (English)

Journal

Surg Technol Int 2019; 34

Publication Date

May 15, 2019

Issn Print

1090-3941

Pages

331-338

Brief description/objective

The Portico™ transcatheter aortic valve implantation (TAVI) system (Abbott Vascular, Santa Clara, CA, USA) was specifically designed to reduce some of the limitations associated with first-generation TAVI devices. Most of the currently available clinical evidence was obtained from randomized studies that compared TAVI to aortic valve replacement using first-generation transcatheter heart valve devices. The aim of this review is to describe the characteristics of the repositionable and retrievable Portico™ system and the technique of implantation, as well as to provide an overview of the most recent outcomes in the literature, along with our institutional experience.